Darmood Wei - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Darmood Wei

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Genes, Chromosomes & Cancer|July 25, 2017

Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276)Youfeng Yang, Cathy D Vocke, Christopher J Ricketts, et al.

Genes, Chromosomes & Cancer|February 2, 2021

Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell linesYoufeng Yang, Christopher J Ricketts, Cathy D Vocke, et al.

Nature Chemical Biology|February 6, 2019

A chemoproteomic portrait of the oncometabolite fumarateRhushikesh A Kulkarni, Daniel W Bak, Darmood Wei, et al.

Oncotarget|March 15, 2018

Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancersCarole Sourbier, Pei-Jyun Liao, Christopher J Ricketts, et al.

Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.

Clinical Genitourinary Cancer|October 6, 2018

Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Genes, Chromosomes & Cancer|July 25, 2017

Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276)Youfeng Yang, Cathy D Vocke, Christopher J Ricketts, et al.

Genes, Chromosomes & Cancer|February 2, 2021

Characterization of genetically defined sporadic and hereditary type 1 papillary renal cell carcinoma cell linesYoufeng Yang, Christopher J Ricketts, Cathy D Vocke, et al.

Nature Chemical Biology|February 6, 2019

A chemoproteomic portrait of the oncometabolite fumarateRhushikesh A Kulkarni, Daniel W Bak, Darmood Wei, et al.

Oncotarget|March 15, 2018

Targeting loss of the Hippo signaling pathway in <i>NF2</i>-deficient papillary kidney cancersCarole Sourbier, Pei-Jyun Liao, Christopher J Ricketts, et al.

Journal of Experimental & Clinical Cancer Research : CR|April 24, 2023

High-throughput and targeted drug screens identify pharmacological candidates against MiT-translocation renal cell carcinomaMartin Lang, Laura S Schmidt, Kelli M Wilson, et al.

Clinical Genitourinary Cancer|October 6, 2018

Updated Recommendations on the Diagnosis, Management, and Clinical Trial Eligibility Criteria for Patients With Renal Medullary CarcinomaPavlos Msaouel, Andrew L Hong, Elizabeth A Mullen, et al.

Pageof 2